Craft

Sernova

Stock Price

$1.1

2022-08-02

Market Capitalization

$409.1 M

2022-08-02

Sernova Summary

Company Summary

Overview
Sernova Biotherapeutics (formerly Sernova Corp.) is a regenerative medicine technology company developing products for the treatment of chronic diseases such as diabetes and hemophilia. It uses therapeutic cells transplanted into a patented implanted medical device, which forms an organ-like environment promoting long-term function and survival of the therapeutic cells.
Type
Public
Status
Active
Founded
2006
HQ
London, CA | view all locations
Website
https://www.sernova.com/
Cybersecurity rating
Sectors

Key People

  • David Swetlow

    David Swetlow, Chief Financial Officer

    • Delfina Siroen

      Delfina Siroen, Senior Director Research and Development

      • Philip M. Toleikis

        Philip M. Toleikis, President, CEO and Director

        • Frank Holler

          Frank Holler, Chairman and Director

          LocationsView all

          1 location detected

          • London, ON HQ

            Canada

            Stiller Centre, 700 Collip Cir #114

          Sernova Financials

          Summary Financials

          Net income (Q2, 2026)
          ($C3.3M)
          Cash (Q1, 2026)
          $C576.0K
          EBIT (Q2, 2026)
          ($C2.6M)
          Enterprise value
          $413.5M

          Footer menu